Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Brock, Judith [VerfasserIn]   i
 Böhmker, Felix [VerfasserIn]   i
 Schuster, Paul Ulrich [VerfasserIn]   i
 Eberhardt, Ralf [VerfasserIn]   i
 Gompelmann, Daniela [VerfasserIn]   i
 Kontogianni, Konstantina [VerfasserIn]   i
 Dittrich, A. Susanne [VerfasserIn]   i
 Benjamin, Nicola [VerfasserIn]   i
 Herth, Felix [VerfasserIn]   i
Titel:Endobronchial lung volume reduction with valves reduces exacerbations in severe emphysema patients
Verf.angabe:Judith Maria Brock, Felix Böhmker, Paul Ulrich Schuster, Ralf Eberhardt, Daniela Gompelmann, Konstantina Kontogianni, Susanne Dittrich, Nicola Benjamin, Felix Herth
E-Jahr:2023
Jahr:4 September 2023
Umfang:7 S.
Fussnoten:Gesehen am 10.06.2024
Titel Quelle:Enthalten in: Respiratory medicine
Ort Quelle:Burlington, Mass. : Harcourt, 1999
Jahr Quelle:2023
Band/Heft Quelle:218(2023) vom: Nov., Artikel-ID 1073994, Seite 1-7
ISSN Quelle:1532-3064
Abstract:Background and objective - Exacerbations drive the progression of chronic obstructive pulmonary disease (COPD). Endoscopic lung volume reduction (ELVR) with valves is an established treatment option for patients with severe emphysema. Post-interventional exacerbations are observed in 8-17% of cases. Whether the exacerbation rate changes in the medium term after ELVR, is not known. - Methods - This is a single-center retrospective analysis of severe emphysema patients with endobronchial valve implantation. The number of exacerbations before and after ELVR was compared, including lung function parameters, exercise capacity and degree of lung volume reduction. The primary endpoint of the study was the number of exacerbations one year after ELVR compared to one year before ELVR. - Results - 129 patients (mean age 64.1 ± 7.7 years, 57% female, mean FEV1 0.8 ± 0.2 l, mean RV 243.4 ± 54.9 %) with ELVR in the years 2016-2019 and complete exacerbation history were analyzed. Patients experienced a mean of 2.5 ± 2.2 moderate and severe exacerbations in the year before ELVR. The number of exacerbations decreased significantly to 1.8 ± 2.2 exacerbations in the first year after ELVR (p = 0.009). The decrease in exacerbation rate was associated with the development of complete lobar atelectasis (r = 0.228. p = 0.009). Accordingly, in 41 patients with complete lobar atelectasis, the decrease in exacerbation rate was higher from 2.8 ± 2.0 to 1.4 ± 1.8 exacerbations (p < 0.001). - Conclusions - ELVR with valves appears promising to reduce the exacerbation rate in COPD patients, especially when the full treatment benefit of complete lobar atelectasis is achieved.
DOI:doi:10.1016/j.rmed.2023.107399
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.1016/j.rmed.2023.107399
 Volltext: https://www.sciencedirect.com/science/article/pii/S0954611123002871
 DOI: https://doi.org/10.1016/j.rmed.2023.107399
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:COPD
 COPD exacerbation
 Endobronchial lung volume reduction
 Endobronchial valves
 Lobar atelectasis
 Lung volume reduction
K10plus-PPN:1890992089
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69222176   QR-Code
zum Seitenanfang